QUARX is an amalgamation of years of experience in market access strategy and deep expertise in biopharma commercial analytics.
We are a team of problem solvers.tinkerers.explorers.learners.consultants.experts.dataphiles.analysts.thinkers.doers.technologists.builders.strategists.architects.partners.inventors.scientists.
Praveen Yedla
Founder
Praveen Yedla
With 20+ years of experience in biopharma commercial analytics & consulting, Praveen specializes in optimizing commercial and access strategy through targeted analytics. Over the years, he has built and led multiple high-performing life sciences analytic consulting practices. His idea of Quarx is a place where you are fueled by the joy of problem solving, strive for excellence in insight quality and experience continuous growth that comes through it’s pursuit.
Andrew Karazim
Strategic Advisor
Andrew Karazim
Andrew Karazim currently leads Aprecia’s commercialization efforts as the Chief Commercial Officer. He brings over 25 years of pharmaceutical and biotechnology experience. Over his 25-year career in the pharma industry, he has held multiple commercial leadership roles at Lilly, Abbott and Kaleo. Andrew serves as the strategic compass to our team through his decades of experience in pharmaceutical commercialization and market access.
Mani Elangovan
AI & Technology Advisor
Mani Elangovan
A serial tech entrepreneur with a track record of building transformative platforms, Mani brings deep expertise in AI, cloud infrastructure, and scalable product design. His latest venture—a cutting-edge AI-driven solution in the insurtech space—redefines how data powers underwriting and claims. As our technology advisor, he actively guides AI infusion initiatives, our product modularization/architecture, and the essential technology stack to accelerate innovation and impact.